CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans

Search results

• Finished

  ARC Training Centre for Personalised Therapeutics Technologies

  Stewart, A. (Investigator 01), Pfleger, K. (Investigator 02), Voelcker, N. (Investigator 03), Pebay, A. (Investigator 04), Dottori, M. (Investigator 05), Lee, P. (Investigator 06), Elnathan, R. (Investigator 07), O'Connor, A. (Investigator 08), Rodger, J. (Investigator 09), Doyle, B. (Investigator 10), Kennedy, B. (Investigator 11), Heng, J. (Investigator 12), Sercombe, T. (Investigator 13), Zheng, M. (Investigator 14) & Volery, T. (Investigator 15)

  Orthocell Pty Ltd

  1/01/18 → 31/12/22

  Project: Research

• Molecular pharmacology of chemokine receptor signalling in cancer

  White, C. (Investigator 01)

  NHMRC National Health and Medical Research Council

  1/01/15 → 31/12/21

  Project: Research